Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cell - PubMed (original) (raw)
Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cell
A Yoshimura et al. Biochim Biophys Acta. 1989.
Abstract
The biosynthesis, processing, and half-life of the drug efflux pump, P-glycoprotein, were studied in human multidrug-resistant KB (KB-C2) cells selected for resistance to colchicine. An antibody directed against a synthetic oligopeptide corresponding to the amino-acid sequence (Glu-393-Lys-408) of P-glycoprotein from human mdr1 cDNA was prepared in rabbits. With immunoblotting and immunoprecipitation, we detected a 140-170 kDa protein in KB-C2 cells but not in parental sensitive KB cells. KB-C2 cells made a 125 kDa precursor that was slowly processed (t1/2 = 45 min) to the mature form of 140-150 kDa. The processing rate of P-glycoprotein was slower than that of low-density lipoprotein receptor. We detected another 160-180 kDa smear band, which might be a completely denatured form of P-glycoprotein. With immunoblotting, a minor band of high molecular mass (greater than 500 kDa) was also detected and this form increased after the cells were treated with chemical cross-linker, 1,5-difluoro-2,4-dinitrobenzene. The half-life of P-glycoprotein was long; no significant loss of P-glycoprotein was observed within 24 h after synthesis. Cells treated with tunicamycin produced a 120 kDa form of P-glycoprotein which was no longer processed but showed stability similar to that of the mature 140-150 kDa form. Agents that reverse multidrug resistance, phorbol ester and transport substrate did not affect the stability of P-glycoprotein.
Similar articles
- Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues.
Ichikawa M, Yoshimura A, Furukawa T, Sumizawa T, Nakazima Y, Akiyama S. Ichikawa M, et al. Biochim Biophys Acta. 1991 Mar 4;1073(2):309-15. doi: 10.1016/0304-4165(91)90136-5. Biochim Biophys Acta. 1991. PMID: 1672608 - Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies.
Yoshimura A, Kuwazuru Y, Sumizawa T, Ichikawa M, Ikeda S, Uda T, Akiyama S. Yoshimura A, et al. J Biol Chem. 1989 Sep 25;264(27):16282-91. J Biol Chem. 1989. PMID: 2476441 - Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells.
Richert ND, Aldwin L, Nitecki D, Gottesman MM, Pastan I. Richert ND, et al. Biochemistry. 1988 Oct 4;27(20):7607-13. doi: 10.1021/bi00420a006. Biochemistry. 1988. PMID: 2905169 - Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells.
Chambers TC, Chalikonda I, Eilon G. Chambers TC, et al. Biochem Biophys Res Commun. 1990 May 31;169(1):253-9. doi: 10.1016/0006-291x(90)91461-z. Biochem Biophys Res Commun. 1990. PMID: 1972016 - Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein.
Safa AR, Stern RK, Choi K, Agresti M, Tamai I, Mehta ND, Roninson IB. Safa AR, et al. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7225-9. doi: 10.1073/pnas.87.18.7225. Proc Natl Acad Sci U S A. 1990. PMID: 1976255 Free PMC article.
Cited by
- Anthracyclines, proteasome activity and multi-drug-resistance.
Fekete MR, McBride WH, Pajonk F. Fekete MR, et al. BMC Cancer. 2005 Sep 13;5:114. doi: 10.1186/1471-2407-5-114. BMC Cancer. 2005. PMID: 16159384 Free PMC article. - Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells.
Zhang L, Ye B, Lin Y, Li YD, Wang JQ, Chen Z, Ping FF, Chen ZS. Zhang L, et al. Front Pharmacol. 2022 Apr 1;13:867128. doi: 10.3389/fphar.2022.867128. eCollection 2022. Front Pharmacol. 2022. PMID: 35450042 Free PMC article. - Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro.
Hill BT. Hill BT. Cytotechnology. 1993;12(1-3):265-88. doi: 10.1007/BF00744668. Cytotechnology. 1993. PMID: 7765329 Review. - Potentiation of the vincristine effect on P388 mouse leukemia cells by a newly synthesized dihydropyridine analogue, PAK-200.
Shudo N, Fujii R, Matsumoto T, Mizoguchi T, Seto K, Sakoda R, Akiyama S. Shudo N, et al. Jpn J Cancer Res. 1992 Sep;83(9):1011-7. doi: 10.1111/j.1349-7006.1992.tb02015.x. Jpn J Cancer Res. 1992. PMID: 1429198 Free PMC article. - BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.
de Lange EC, de Bock G, Schinkel AH, de Boer AG, Breimer DD. de Lange EC, et al. Pharm Res. 1998 Nov;15(11):1657-65. doi: 10.1023/a:1011988024295. Pharm Res. 1998. PMID: 9833984
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous